Erectile Dysfunction

Hypnion is developing a compound, HY10275, which is of interest to Lilly.

The compound is undergoing testing.

-Contact: 201-938-5400 Related Blog Posts & Articles E-mail RSS 7:55AM 4/16/2007Mattel posts quarterly profit on 19% sales growth7:51AM 4/16/2007Sallie Mae going private for $25 billion7:47AM 4/16/2007Wachovia's quarterly net income climbs more than 30%7:38AM 4/16/2007Stock futures up as earnings season heats up; Citi in focus7:29AM 4/16/2007Citigroup first-quarter profit falls 11% after cost-review charge More news Sign up to receive the Weekend TV Show Preview e-Newsletter.

E-Mail Address: SPONSORED LINKS Get listed here Most Popular READ E-MAILED EDITOR'S PICK Sallie Mae to be sold for $25 billion: WSJGold jumps, but gold bugs still suspiciousNikkei leads broad regional advance; Canon, China Mobile riseGood news for investors in online gamingStocks in focus for MondayAngst in affluent AmericaStrong quarterly earnings expected for three big U.S.

banksCORRECT: China sets sights on Boeing, AirbusEuropean shares gain ground as banking stocks riseSoftware stalwarts test market magnanimity Gold jumps, but gold bugs still suspiciousSallie Mae to be sold for $25 billion: WSJAfter b...

Read more...